Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:22

RNS Number : 0199K
Softcat PLC
05 April 2018
 

Softcat plc (the "Company")

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities

 

 

The following notification relates to the award of nil-cost options to person discharging managerial responsibilities ("PDMR") on 4 April 2018 under the Softcat plc Long Term Incentive Plan ("LTIP").  

 

Softcat plc Long Term Incentive Plan

 

On 4 April 2018, an award of nil-cost options to acquire 66,864 shares was made to Graeme Watt, a director and PDMR. The number of shares over which the nil-cost option was awarded has been calculated by reference to the closing middle market quotation of the ordinary shares derived from the Daily Official List on the dealing day preceding the date of grant (6.73 pence). The award will vest subject to the performance conditions outlined below.

 

 

Performance Conditions and Vesting of Awards

 

These nil-cost options are subject to the rules of the LTIP and will vest depending on performance against Total Shareholder Return ("TSR") and Earnings per Share ("EPS") targets as measured over a three year performance period.

 

50% of the Award will be subject to the Company's relative TSR performance against the FTSE 250 (excluding real estate and investment trusts):

 

TSR performance % of Award vesting

Below median Nil

At median 30%

Upper quartile or above 100%

 

50% of the Award will be subject to the Company's EPS for FY 2020:

 

EPS Growth % of Award vesting

Less than 23.7 pence Nil

23.7 pence 20%

26.9 pence or above 100%

 

There will be straight line vesting between the points as outlined above.

 

The normal date of vesting for the nil-cost options outlined above will be 4 April 2021 and the last date for exercise will be 3 April 2028, with dividend equivalents payable in respect of the vesting of nil-cost options in accordance with the rules of the LTIP.

 

For further information on the LTIP, please refer to the Company's Annual Report and Accounts.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graeme Watt

 

2.

Reason for the notification

a)

Position / status

Chief Executive

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Softcat plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.0005 each

 

 

ISIN: GB00BYZDVK82

b)

Nature of the transaction

Grant of nil cost option over Ordinary Shares of £0.0005 each under the Softcat plc Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.00

66,864

d)

Aggregated information

Aggregated volume

Price

 

N/A

e)

Date of the transaction

 

2018-04-04

f)

Place of the transaction

 

Outside a trading venue

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGDKKGGRZM
Date   Source Headline
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding
1st Mar 202312:27 pmRNSTotal Voting Rights
8th Feb 20231:05 pmRNSDirector/PDMR Shareholding
1st Feb 202312:41 pmRNSTotal Voting Rights
17th Jan 20237:05 amRNSDirectorate Change
10th Jan 20232:23 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:34 amRNSTotal Voting Rights
3rd Jan 202311:31 amRNSDirector/PDMR Shareholding
22nd Dec 20223:00 pmRNSDirector/PDMR Shareholding
14th Dec 202210:12 amRNSResult of AGM
8th Dec 202212:29 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:57 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:54 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSChief Financial Officer Appointment
1st Dec 202211:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.